Program Schedule

What's Hot in ID and HIV

Wednesday, October 8, 2014: 1:30 PM-3:30 PM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
Co-organized with the Center for Global Health Policy

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • outline clinically significant research findings in ID and HIV over the past year
  • describe basic science findings likely to impact clinical practice within the next year
  • describe how research advances in the past year will impact their practice
  • describe recent discoveries in the pathogenesis of infectious disease
  • discuss recent publications of importance in infectious disease practice
  • debate current controversies in infectious disease

Target Audience: Investigators, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Fellows, Clinicians, Researchers, Public health practitioners, Members-in-training

Tracks: HIV-STD-TB, Adult ID

Moderators:  Rochelle Walensky, MD, MPH, FIDSA, Massachusetts General Hospital and Robert Read, MD, FIDSA, University of Sheffield and Sheffield Teaching Hospitals Sheffield

1:30 PM
What's Hot in HIV (Clinical Research)
Joel Gallant, MD, MPH, FIDSA
2:00 PM
2:30 PM
What's Hot in ID (Basic Science)
Joel Ernst, MD, FIDSA
3:00 PM
What's Hot in ID (Clinical Science)
John G. Bartlett, MD, FIDSA

CME Credits: Maximum of 2 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-090-L02-P


R. Walensky, None

R. Read, None

J. Gallant, Bristol-Myers Squibb: Investigator, Research support
CytoDyn, Ltd.: Investigator, Research support
Gilead Sciences: Investigator and Scientific Advisor, Consulting fee and Research support
Merck & Co.: Investigator and Scientific Advisor, Consulting fee and Research support
Takara Bio, Inc.: Scientific Advisor, Consulting fee
Sangamo BioSciences: Investigator, Research support
Vertex Pharmaceuticals: Investigator, Research support
ViiV Healthcare: Investigator, Research support
Janssen Therapeutics: Scientific Advisor, Consulting fee

B. Hahn, None

J. Ernst, None

J. G. Bartlett, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek